| Literature DB >> 22640590 |
Ashlyn Swift-Gallant1, Lee Niel, D Ashley Monks.
Abstract
Sexual differentiation of the nervous system occurs via the interplay of genetics, endocrinology and social experience through development. Much of the research into mechanisms of sexual differentiation has been driven by an implicit theoretical framework in which these causal factors act primarily and directly on sexually dimorphic neural populations within the central nervous system. This review will examine an alternative explanation by describing what is known about the role of peripheral structures and mechanisms (both neural and non-neural) in producing sex differences in the central nervous system. The focus of the review will be on experimental evidence obtained from studies of androgenic masculinization of the spinal nucleus of the bulbocavernosus, but other systems will also be considered.Entities:
Year: 2012 PMID: 22640590 PMCID: PMC3464926 DOI: 10.1186/2042-6410-3-12
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 5.027
Site of action in the spinal nucleus of the bulbocavernosus
| | | |
| Androgens can attenuate cell death in cultured motoneurons | Motoneuron | [ |
| Androgen receptor is expressed in muscle but not motoneuron during critical period | Muscle, not motoneuron | [ |
| Ablation of spinal cord containing SNB does not prevent masculinization of target muscle | Not motoneuron | [ |
| Ablation of target muscle prevents masculinization of SNB motoneurons | Muscle | [ |
| Anti-androgen delivered to target muscles prevent masculinization of SNB motoneurons | Muscle | [ |
| Administering CNTFa, trkB or trkC antagonists to target muscle more effective than systemic administration in preventing masculinization of SNB motoneurons | Muscle | [ |
| SNB motoneurons of androgenized X | Not motoneuron | [ |
| Selective genetic muscle | Not only myocytes | [ |
| Selective genetic deletion of Ar in myocytes reduces but does not prevent masculinization of SNB | Not only myocytes | [ |
| | | |
| Neonatal axotomy of SNB motoneurons prevents normal soma size | Muscle | [ |
| | | |
| ER agonist/antagonist delivered to target muscles more effective that systemic delivery in regulating dentritic outgrowth of SNB motoneurons | Muscle | [ |
| | | |
| Axotomy of SNB motoneurons prevents androgenic maintenance of SNB motoneuron size | Muscle | [ |
| AR agonists or antagonists delivered unilaterally to target muscles do not affect ipsilateral motoneurons | Motoneuron | [ |
| Size of SNB motoneurons of androgenized X | Motoneuron | [ |
| Selective overexpression of | Not myocyte | [ |
| | | |
| Local injection of target muscle extracts from castrated males increases CGRP in SNB motoneurons | Muscle | [ |
| Axotomy of SNB motoneurons affects AR | Muscle | [ |
| CGRP, CDH2 in SNB motoneurons of androgenized X | Motoneuron | [ |
| | | |
| AR agonists or antagonists delivered unilaterally to target muscles do affect ipsilateral motoneurons | Muscle | [ |
| Selective overexpression of | Myocyte | [ |